BioRN News and Highlights August 2024

*|MC:SUBJECT|*

BioRN News August 2024

View this email in your browser

Dear *|FNAME|* *|LNAME|*,

It´s SUMMER TIME:

Whether at home, on vacation or in the office - we're sure you're enjoying the summer just as much as we are!
That's why you're receiving a short version of our newsletter today with a foretaste of the “post-summer season”.

On September 5th we start with the BioRN AG Lab Sustainability
At BioRN, we believe in building a future where Life Science innovation and Sustainability go hand in hand. We're excited to launch our new Sustainability Initiative that brings academia and business together to share experiences and create practical solutions for everyday challenges in the lab.

Mark your calendar for the BioRN Lounge on September 24th at the Urban Kitchen. We are looking forward to Klaas Rackebrand, SCALANIA AG and his presentation "Startup financing - alternatives and EU best practices"

Look forward to an insightful M2M Member to Member session on September 26th featuring Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology. We are curious to learn about the company's success story with the mission to develop disruptive therapies for the ophtaphalmic.

Only five weeks to go until BioRN is in FESTIVAL FEVER with its Life Science Week!
In the week from October 8 to 10 we celebrate innovation in Life Science.
The Life Science Week starts on October 8 with the premiere of the Industry-Academia Day on the topics Neuroscience and Immunology, which is tailored and offered exclusively for BioRN pharma partners.

The BioRN Annual Conference will open its doors on October 9th.
Haven´t registered yet?
With 26 exhibitors and an extensive program the BAC is THE place to be if you are keen on tapping into our vibrant Life Science ecosystem!
Get an overview of the latest scientific breakthroughs our region is generating and be captivated by presentations from, DKFZ, Heidelberg Pharma, Heidelberg Epignostix, Heidelberg University, BASF, KiTZ, Hummingbird and the NMI, sharing their latest findings with you.
Also pay attention to the young scientists at the Young Scientists Pitch Award and learn how their innovations may shape the future of patients´ health.

Enjoy more news from our network, take a look at the new calls at 04I Innovation Promotion and
come back refreshed!
Kind regards

Stephanie Füller
PR Manager
BioRN Life Science Cluster Rhine-Neckar

01 | Research Highlights & News

AbbVie

European Commission Grants Second Indication Approval for TEPKINLY® (epcoritamab) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma [more]
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis [more]

NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines [more]

Ascendis Pharma: FDA Approves YORVIPATH® (Palopegteriparatide) as the First and Only Treatment for Hypoparathyroidism in Adults [more]

DKFZ:

New vaccine against cervical cancer combines prophylactic and therapeutic activities [more]
Validated target for personalized cancer immunotherapy [more]
Prestigious award for Lena Maier-Hein from the DKFZ [more]
Prostate cancer: Can AI help to avoid unnecessary biopsies? [more]
Physical training improves quality of life in advanced breast cancer [more]
Surprising finding in glioblastomas: Islands of potent immune cells in the local bone marrow [more]

EMBL:

The forces behind chromosome repulsion and attraction during cell division [more]
Developing a simple, cost-effective method to study an important protein modification [more]
Why clinical trials stop: the role of genetics [more]
Gut microbes implicated in bladder cancer [more]

Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb [more]

Heidelberg University:

Award for work on the evolution of the mammalian brain [more]
3D Laser Printing with Bioinks from Microalgae [more]
Peptide Boronic Acids: New Prospects for Immunology [more]
Very slow developing malaria pathogens could be suitable as a vaccine [more]

Heidelberg University Hospital (UKHD):

Skin flora as the key to cancer therapy? [more]
Targeted therapy for cancer of unknown origin [more]

Novaliq Receives Positive CHMP Opinion FOR Vevizye® in Dry EYE Disease [more]

PL BioScience secures 7.8 million euros in Series A financing [more]

02 | New Members

Actome GmbH, a high-potential startup recognized by the European Innovation Council (EIC), is advancing protein analysis. Based in Freiburg, Actome has developed an innovative method called PICO (Protein Interaction Coupling) Technology, which allows scientists worldwide to analyze and quantify proteins, protein-protein interactions, and post-translational modifications with high throughput. This advanced technology significantly enhances research efficiency. Imagine completing 96 Western Blots or Co-Immunoprecipitations in just one day—transforming the pace of scientific discovery.

Recently, Actome has expanded its product portfolio to include advanced tools for the quantification and characterization of extracellular vesicles. With the financial support of the EIC, Actome is now developing a method for the absolute quantification of proteins in single cells, pushing the boundaries of cellular analysis."

Homo Novus is working in all ranges of laboratory services with more than 20 years of experience in meeting individual requirements and presenting customer-specific solutions. Their 300 square meter-laboratory is qualified according to EU GMP with clean rooms classified from grade D to grade A. They offer professional and order-specific services, such as: production, filling of small batches under aseptic conditions or using terminal sterilization and contract research & development services.

With their highly skilled team, they work flexibly and reliably with tailored solutions to meet your individual requirements.

Medea Biopharma GmbH specializes in the development of a new generation of sustainable and eco-friendly antibacterial solutions based on bacteriophages (phages), designed to solve the global crisis of antimicrobial resistance.

Phages are natural bacterial killers, which are highly specific and without side effects. These innovative alternatives aim to replace conventional chemical antibiotics, copper-based solutions, and harmful pesticides, offering effective and environmentally responsible ways to combat harmful bacteria across diverse sectors, including human health, animal wellbeing, and agriculture.

At SURFACtoBioTech, they are pioneering the future of biotechnology services by empowering laboratories to embrace efficiency and sustainability.

Their focus is on revolutionizing the field through droplet-based microfluidics, offering bespoke chemical solutions and developing user-friendly, plug-and-play instruments tailored to your experimental needs. Their mission is to facilitate your transition to cutting-edge droplet-based biotechnologies, enabling a significant reduction in environmental impact, resource usage, and an increase in laboratory efficiency. Join them in leading the shift towards a more sustainable and efficient future in biotechnology.

The Technical University of Darmstadt is a synonym for excellent, relevant science. Global transformations – from the energy transition via Industry 4.0 to artificial intelligence – are posing enormous challenges. They are playing a crucial role in helping to shape these far-reaching processes of change with outstanding insights and forward-looking study opportunities.

Since TU Darmstadt was founded in 1877, they have been one of Germany’s most international universities; as a European technical university, they are committed to European values and European integration. Their home is the metropolitan region Frankfurt-Rhine-Main. With their partners in the Alliance of Rhine-Main Universities, they continue the development of this globally attractive science location.

Their cutting-edge research is pooled in three fields: Energy and Environment, Information and Intelligence, Matter and Materials. Large-scale, problem-based interdisciplinarity involving the engineering sciences, natural sciences, humanities and social sciences is the hallmark of their research and study. They foster intensive, productive interaction with society, business and politics. Such collaborative polyphony generates effective, long-term progress towards sustainable development worldwide.

03 | Event Spotlights

04 | Event Calendar & Discounts

Industry meets Women in Pharma, sponsored by KyooBe Tech
September 13, 2024 - Leinfelden-Echterdingen, Germany >>

Wnt Meeting 2024
September 25-27, 2024 - Heidelberg, Germany >>

WorkLifePortal (WLP) Infoveranstaltung
September 26, 2024 - Online >>

Industry Academia Day
October 08, 2024 - Heidelberg, Germany
This event is exclusively tailored and offered to the BioRN pharma partners.

BioRN Annual Conference 2024
October 9, 2024 - Heidelberg Congress Center (HCC) Heidelberg, Germany
Information about exhibition and sponsoring package on our website.

Life Science Investors’ Day
October 10, 2024 - Heidelberg, Germany >>
We would be delighted to welcome you as an investor, if you are interested in therapeutics, diagnostics, and deep-tech digital health.

6th Nordic Conference on Sustainable Healthcare
October 15, 2024 - Malmä, Sweden >>
BioRN Members receive a 20 % discount.

Festival of Biologics
October 15-17, 2024 - Basel, Switzerland >>
BioRN members receive free tickets (limited to 50 tickets), after that there is a 20 % discount.

MSCoreSys Industry Symposium
October 22, 2024 - Dresden, Germany >>

BIO-Europe® 2024
November 04-06, 2024 - Stockholm, Sweden
November 12–13, 2024 - Digital Partnering >>
BioRN Members receive a 15 % discount.

BioFIT 2024 - Fostering Innovation & Transfer
December 03-04, 2024 - Lille, France & Online >>
BioRN Members receive a 20 % discount.

05 | Innovation Promotion

In this section we provide selected information on funding calls and events:

EIT Health Catapult: Deadline extended! Make sure to submit your abstract by September 1st.
Competition and training program that showcases life sciences and health tech start-ups to leading experts and investors across Europe. The program awards the best business concepts, fast-tracking start-ups to become part of the EIT Health Community of world-leading companies.
[more]

Bio Europe November 4-6 in Stockholm. Apply asap!
Take the opportunity to make international contacts with your start-up and join BW_i and BIOPRO at the German joint stand.
[more]

Life Science Accelerator BW: Application deadline September 15th
The Life Science Accelerator Baden-Württemberg is a 12-month Accelerator program for life science startups in the pre-seed or seed phase to optimize their development process. The program includes high-quality workshops and a stellar network of industry experts and mentors to strategically progress through different stages.
[more]

Guideline for the funding of trans- and interdisciplinary research networks on the topic of ‘Pandemic prevention and response as part of a One Health approach: Deadline September 4th
Funding will be provided for inter- and transdisciplinary collaborative projects on new or re-emerging pathogens with epidemic/pandemic potential and on AMR of pathogens that cause infectious disease in humans.
[more]

Fresh Capital: The following 3 Funds were closed:
Eir Partners Closes $496M Investment Program II  [more]
Vsquared closes second fund of €214m to cash in on Europe’s deeptech boom  [more]
HTGF Opportunity Fund launches with 660 million euros for the growth phase  [more]

06 | Open Positions

PEPperPRINT GmbH:

Verwaltungsassistent / Werkstudent (m/w/d) [more]
Scientist with a biomedical background as Freelance France Business Development Manager (m/f/d) [more]
Chemielaborant/in, CTA (m/w/d) [more]